These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21922303)

  • 21. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats.
    Peng ZY; Carter MJ; Kellum JA
    Crit Care Med; 2008 May; 36(5):1573-7. PubMed ID: 18434884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations.
    Pilz G; Fraunberger P; Appel R; Kreuzer E; Werdan K; Walli A; Seidel D
    Crit Care Med; 1996 Apr; 24(4):596-600. PubMed ID: 8612409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dantrolene, an inhibitor of intracellular calcium release, fails to increase survival in a rat model of intra-abdominal sepsis.
    Cameron EM; Zhuang J; Menconi MJ; Phipps R; Fink MP
    Crit Care Med; 1996 Sep; 24(9):1537-42. PubMed ID: 8797628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte colony-stimulating factor has differing effects comparing intravascular versus extravascular models of sepsis.
    Sevransky JE; Parent C; Cui X; Karzai W; Fitz Y; Banks SM; Gerstenberger E; Danner RL; Natanson C; Eichacker PQ
    J Trauma; 2004 Sep; 57(3):618-25. PubMed ID: 15454812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed administration of D-Ala2-D-Leu5-enkephalin, a delta-opioid receptor agonist, improves survival in a rat model of sepsis.
    Tang CW; Feng WM; Du HM; Bao Y; Zhu M
    Tohoku J Exp Med; 2011 May; 224(1):69-76. PubMed ID: 21551984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil inhibition with L-selectin-directed MAb improves or worsens survival dependent on the route but not severity of infection in a rat sepsis model.
    Haley M; Parent C; Cui X; Kalil A; Fitz Y; Correa-Araujo R; Natanson C; Danner RL; Banks SM; Eichacker PQ
    J Appl Physiol (1985); 2005 Jun; 98(6):2155-62. PubMed ID: 15677732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-TNF antibody treatment has no positive effect on survival in a model of pneumococcal sepsis in pigs.
    Gawad KA; Schneider C; Brinken B; Hufländer A; Diederichs B; Mack D; Gutensohn K; Izbicki JR
    J Invest Surg; 2001; 14(5):291-7. PubMed ID: 11700923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned.
    Reinhart K; Karzai W
    Crit Care Med; 2001 Jul; 29(7 Suppl):S121-5. PubMed ID: 11445746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Early Intravenous Fluids Provided by Paramedics and Subsequent In-Hospital Mortality Among Patients With Sepsis.
    Lane DJ; Wunsch H; Saskin R; Cheskes S; Lin S; Morrison LJ; Scales DC
    JAMA Netw Open; 2018 Dec; 1(8):e185845. PubMed ID: 30646296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of heparin administration in animal models of sepsis: a prospective study in Escherichia coli-challenged mice and a systematic review and metaregression analysis of published studies.
    Li Y; Sun JF; Cui X; Mani H; Danner RL; Li X; Su JW; Fitz Y; Eichacker PQ
    Crit Care Med; 2011 May; 39(5):1104-12. PubMed ID: 21317646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma Resuscitation Improved Survival in a Cecal Ligation and Puncture Rat Model of Sepsis.
    Chang R; Holcomb JB; Johansson PI; Pati S; Schreiber MA; Wade CE
    Shock; 2018 Jan; 49(1):53-61. PubMed ID: 28591008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsis.
    Porat R; Paddock HN; Schwaitzberg SD; Connolly RJ; Wilkens T; Dasch JR; Gascon MP; Hutchison JS; Ythier A; Wallach D
    Crit Care Med; 1995 Jun; 23(6):1080-9. PubMed ID: 7774220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New therapies in sepsis.
    Vincent JL
    Chest; 1997 Dec; 112(6 Suppl):330S-338S. PubMed ID: 9400898
    [No Abstract]   [Full Text] [Related]  

  • 34. Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit.
    Stack AM; Saladino RA; Thompson C; Sattler F; Weiner DL; Parsonnet J; Nariuchi H; Siber GR; Fleisher GR
    Crit Care Med; 1995 Sep; 23(9):1512-8. PubMed ID: 7664553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis.
    Seymour CW; Gesten F; Prescott HC; Friedrich ME; Iwashyna TJ; Phillips GS; Lemeshow S; Osborn T; Terry KM; Levy MM
    N Engl J Med; 2017 Jun; 376(23):2235-2244. PubMed ID: 28528569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database.
    Marik PE; Linde-Zwirble WT; Bittner EA; Sahatjian J; Hansell D
    Intensive Care Med; 2017 May; 43(5):625-632. PubMed ID: 28130687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluid resuscitation in severe sepsis and septic shock: albumin, hydroxyethyl starch, gelatin or ringer's lactate-does it really make a difference?
    Su F; Wang Z; Cai Y; Rogiers P; Vincent JL
    Shock; 2007 May; 27(5):520-6. PubMed ID: 17438457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis--a randomized, clinical trial.
    Clark MA; Plank LD; Connolly AB; Streat SJ; Hill AA; Gupta R; Monk DN; Shenkin A; Hill GL
    Crit Care Med; 1998 Oct; 26(10):1650-9. PubMed ID: 9781721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis.
    Cui X; Li Y; Moayeri M; Choi GH; Subramanian GM; Li X; Haley M; Fitz Y; Feng J; Banks SM; Leppla SH; Eichacker PQ
    J Infect Dis; 2005 Feb; 191(3):422-34. PubMed ID: 15633102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sophorolipids improve sepsis survival: effects of dosing and derivatives.
    Hardin R; Pierre J; Schulze R; Mueller CM; Fu SL; Wallner SR; Stanek A; Shah V; Gross RA; Weedon J; Nowakowski M; Zenilman ME; Bluth MH
    J Surg Res; 2007 Oct; 142(2):314-9. PubMed ID: 17719064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.